权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Minority Based Community Clinical Oncology Program

基于少数民族的社区临床肿瘤学计划

基本信息

批准号：
7849785
负责人：
DAVID J PEACE
金额：
$ 69.26万
依托单位：
UNIVERSITY OF ILLINOIS AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
起止时间：
1997-08-15 至 2012-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7849785
关键词：
Address African American Ancillary Study Antineoplastic Protocols Area Arts Authorization documentation Awareness Breast Cancer Center Cancer Patient Cancer Prevention Trial Cancer and Leukemia Group B Centers for Population Health Chicago Clinic Clinical Research Collaborations Communities Community Clinical Oncology Program Community Health Centers Country County Eastern Cooperative Oncology Group Family Practice Federally Qualified Health Center Funding Future Gynecologic Oncology Group Health Health Personnel Health system Hematology Illinois Indiana Individual Internal Medicine Low income Malignant neoplasm of prostate Medical center Michigan Minority Minority-Based Community Clinical Oncology Program National Cancer Institute National Surgical Adjuvant Breast and Bowel Project Oncologist Patients Population Positioning Attribute Prevention Primary Health Care Research Resources Selenium Selenium and Vitamin E Efficacy Trial Services Site Southwest Oncology Group Structure United States Public Health Service Universities Veterans Vitamin E Woman Women&apos s Health base cancer care cancer health disparity cancer prevention cancer therapy clinical research site control trial cooking health disparity health literacy member men oncology outreach programs suburb

项目摘要

DESCRIPTION (provided by applicant): 1. To maintain the successful retention of African-American men to the Selenium and Vitamin E Selenium and Vitamin E Cancer Prevention Trial (SELECT) and the successful recruitment and retention of African- American men to SELECT ancillary studies. 2. To provide access to state-of-the-art cancer treatment for minority individuals by increasing minority participation in cancer treatment protocols using proven recruitment and retention strategies: 3. To raise the level of cancer prevention and control (CaP/C) opportunities offered throughout the Chicago and Northwest Indiana region by partnering with two major NCI-funded programs [Center for Population Health and Health Disparities (CPHHD) and the Patient Navigator Research Program (PNRP)] and Ingalls Health System. The UIC MB-CCOP plans to leverage these partnerships to establish a structure and framework to overcome the barriers to recruitment and retention and provide access to CaP/C trials to minority communities in this entire region. 4. To increase the awareness, understanding, and involvement of health care providers, community leaders, and local organizations in UIC MB-CCOP activities. These aims will be achieved by an established minority clinical research headquarters within the UIC Section of Hematology/Oncology and utilizes several research bases: Cancer and Leukemia Group B (CALGB): Main Member since 1996 Southwest Oncology Group (SWOG): CCOP Expanded Access Pilot Program (1998) Eastern Cooperative Oncology Group (ECOG): Accepted July 15, 2005 (by NCI permission) Gynecologic Oncology Group (GOG) National Surgical Adjuvant Breast and Bowel Project (NSABP): STAR & P-4 The University of Michigan CCOP Research Base: CaP/C The University of Rochester CCOP Research Base: CaP/C

描述（由申请人提供）：1。保持非裔美国男性成功保留硒和维生素E硒和维生素E癌症预防试验（SELECT），并成功招募和保留非裔美国男性参加SELECT辅助研究。2.为少数群体个人提供最先进的癌症治疗，通过使用经过验证的招募和保留策略增加少数群体对癌症治疗方案的参与：3.通过与两个主要的NCI资助计划[人口健康与健康差异中心（CPHHD）和患者导航研究计划（PNRP）]和Ingalls卫生系统合作，提高整个芝加哥和西北印第安纳州地区提供的癌症预防和控制（CaP/C）机会的水平。UIC MB-CCOP计划利用这些伙伴关系建立一个结构和框架，以克服招聘和保留的障碍，并为整个地区的少数民族社区提供CaP/C试验。4.提高卫生保健提供者、社区领导人和地方组织对UIC MB-CCOP活动的认识、理解和参与。这些目标将通过UIC血液学/肿瘤学部门内建立的少数民族临床研究总部实现，并利用几个研究基地：癌症和白血病组B（CALGB）：自1996年以来的主要成员西南肿瘤组（SWOG）：CCOP扩大使用试点计划（1998）东部肿瘤协作组（ECOG）：2005年7月15日接受（经NCI许可）妇科肿瘤组（GOG）国家外科辅助乳腺和肠道项目（NSABP）：星星和P-4密歇根大学CCOP研究基地：CaP/C罗切斯特大学CCOP研究基地：CaP/C